“Technology and Digitalization will Continue to Provide Further Boost to the Sector”
Suresh Vazirani, Founder Chairman & Managing Director, TransasiaErba Group, in his keynote address at the virtual second edition of Elets Diagnostics Leadership talked about the phenomenal growth and opportunities in the Indian Diagnostics sector due to Covid-19.
“The COVID-19 pandemic has brought lab medicine to the forefront, and the government has realized the role of clinical diagnostics in the healthcare value chain. Technology and digitalization will continue to provide further boost to the sector. Transasia’s R&D centres in India, US and Europe continue to work on technologies that will offer affordable diagnostics to the 650 million population who still do not have access to quality diagnostics. The volume of diagnostic tests will see an accelerated growth of 20- 22%. The Indian IVD industry is likely to witness a growth of 15% over the next 5 years,” cited Mr. Suresh Vazirani, Founder Chairman and Managing Director, Transasia-Erba International Group of Companies, during his keynote address at the virtual 2nd ELETS Diagnostic Leadership Summit 2021.
post_id:
uld_count:
Cookie not set
Like
Dislike
Value 1: 0
Value 2: 10
